EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia

Hayatte-Dounia Mir, Giada Giorgini, Irene Santos-García, Elizabeth Dumais, Carmen Rodríguez-Cueto, Eva de Lago, Cristoforo Silvestri iD, Nicolas Flamand iD, Javier Fernández-Ruiz, Vincenzo Di Marzo

The FASEB Journal · 2026

DOI: 10.1096/fj.202502312rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Hayatte-Dounia Mir und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médicine (DMED), Centre de Recherche de l'Institut Universitaire de Pneumologie et Cardiologie (CRIUCPQ), Faculté de Médicine (FMED), …. Hauptthemen laut MEDLINE: Endocannabinoids, Frontotemporal Dementia, Signal Transduction, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federación Española de Enfermedades Raras (FEDER), Canada Excellence Research Chairs, Government of Canada (CERC), UL|Sentinelle Nord, Université Laval (Sentinel North).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Frontotemporal dementia (FTD) is a group of early onset and progressive disorders, characterized by degeneration in the frontal and temporal lobes, and subsequent deterioration in cognition, personality, social behavior, and language, with aggregates of the RNA‐binding protein TDP‐43 being present in ~45% of the cases. We reported alterations of the endocannabinoidome (eCBome) in the brain of a TDP‐43 mouse model of FTD. Here we investigated the small intestinal eCBome, oxylipins, and, preliminarily, the gut microbiome. The duodenum, jejunum, and ileum of TDP‐43 overexpressing versus wildtype mice were investigated. Lipid mediators were measured by HPLC‐MS/MS, and mRNA expression of genes involved in eCBome mediator action and metabolism, or intestinal permeability and inflammation, was analyzed by qPCR. Intestinal content microbiota composition and fecal short‐chain fatty acids were studied by 16S DNA sequencing and GC‐FID, respectively. Alterations were observed in TDP‐43 mice for polyunsaturated fatty acids, N ‐acyl‐ethanolamines, and oxylipins in the duodenum and the jejunum, and for oxylipins and 2‐monoacylglycerols in the ileum. Regarding the receptors, mRNA expression of Cnr1 and Gpr119 was increased in the ileum, and that of Pparg in the duodenum, where Gpr55 was instead down‐regulated. Regarding the enzymes, Faah and Napepld expression was increased in the ileum. Preliminary gut microbiota data suggest increases of Paraprevotella and Monoglobus in the feces, of DNF00809 in the ileum, and of Butyricicoccus , Candidatus_Arthromitus , and Oscillospira in the cecum, where Paraprevotella , Mucispirillum , and Akkermansia were instead decreased. Fecal acetic, butyric, and isobutyric acid were reduced. We suggest the existence of lipid signal‐mediated gut‐brain interactions in FTD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsFrontotemporal DementiaSignal TransductionDNA-Binding ProteinsOxylipinsAnimalsMiceMaleDisease Models, AnimalGastrointestinal MicrobiomeMice, TransgenicMice, Inbred C57BLHumans

Stichwörter der Autor:innen

FAAHTDP‐43endocannabinoidomefrontotemporal dementiagut‐brain axismicrobiotashort‐chain fatty acids

Substanzen

EndocannabinoidsDNA-Binding ProteinsOxylipins

Autor:innen und Institutionen

  • Département de Médicine (DMED), Centre de Recherche de l'Institut Universitaire de Pneumologie et Cardiologie (CRIUCPQ), Faculté de Médicine (FMED), Université Laval, Québec, Canada.
  • Canada Research Excellence Chair in the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, Canada.
  • Unité Mixte Internationale en Recherche Chimique et Biomoléculaire sur le Microbiome et son Impact sur la Santé Métabolique et la Nutrition (UMI-MicroMeNu) entre l'Université Laval, Québec, Canada.
  • Institute of Biomolecular Chemistry (ICB-CNR), Consiglio Nazionale Delle Ricerche, Pozzuoli, Italy.
  • Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigación en Neuroquímica, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

ORCID-Profile: Cristoforo Silvestri, Nicolas Flamand

Förderung

  • Federación Española de Enfermedades Raras (FEDER)
  • Canada Excellence Research Chairs, Government of Canada (CERC)
  • UL|Sentinelle Nord, Université Laval (Sentinel North)
  • Sentinelle Nord, Université Laval

Zitieren

APA

Mir, H. D., Giorgini, G., Santos-García, I., Dumais, E., Rodríguez-Cueto, C., de Lago, E., Silvestri, C., Flamand, N., Fernández-Ruiz, J., & Di Marzo, V. (2026). Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia. The FASEB Journal. https://doi.org/10.1096/fj.202502312rr

Vancouver

Mir HD, Giorgini G, Santos-García I, Dumais E, Rodríguez-Cueto C, de Lago E, et al. Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia. The FASEB Journal. 2026. doi:10.1096/fj.202502312rr

BibTeX
@article{Mir2026,
  author = {Mir, Hayatte-Dounia and Giorgini, Giada and Santos-García, Irene and Dumais, Elizabeth and Rodríguez-Cueto, Carmen and de Lago, Eva and Silvestri, Cristoforo and Flamand, Nicolas and Fernández-Ruiz, Javier and Di Marzo, Vincenzo},
  title = {Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP‐43 Mouse Model of Frontotemporal Dementia},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202502312rr}
}
Kostenlos starten →